LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $983,707 | +161.5% | 16,417 | +214.6% | 0.00% | – |
| Q2 2023 | $376,218 | -24.0% | 5,218 | -22.4% | 0.00% | – |
| Q1 2023 | $494,838 | -58.0% | 6,727 | -50.8% | 0.00% | -100.0% |
| Q3 2022 | $1,177,000 | -4.9% | 13,665 | +24.2% | 0.00% | – |
| Q1 2022 | $1,237,000 | -84.3% | 11,000 | -78.4% | 0.00% | -100.0% |
| Q4 2021 | $7,862,000 | +13.8% | 50,896 | +2.7% | 0.00% | +50.0% |
| Q3 2021 | $6,908,000 | -11.1% | 49,582 | -16.3% | 0.00% | -33.3% |
| Q2 2021 | $7,772,000 | -87.5% | 59,241 | -85.5% | 0.00% | -90.3% |
| Q1 2021 | $62,125,000 | +1344.8% | 407,512 | +842.5% | 0.03% | +1450.0% |
| Q4 2020 | $4,300,000 | -50.7% | 43,238 | -52.8% | 0.00% | -66.7% |
| Q3 2020 | $8,723,000 | -64.9% | 91,515 | -58.8% | 0.01% | -66.7% |
| Q2 2020 | $24,829,000 | +188.4% | 221,982 | +87.5% | 0.02% | +100.0% |
| Q1 2020 | $8,610,000 | +146.0% | 118,400 | +252.8% | 0.01% | +125.0% |
| Q4 2019 | $3,500,000 | +651.1% | 33,556 | +616.5% | 0.00% | +300.0% |
| Q3 2019 | $466,000 | -49.1% | 4,683 | -41.7% | 0.00% | -50.0% |
| Q2 2019 | $916,000 | -23.0% | 8,027 | -15.2% | 0.00% | 0.0% |
| Q1 2019 | $1,190,000 | -68.5% | 9,462 | -66.0% | 0.00% | -75.0% |
| Q4 2018 | $3,773,000 | +96.1% | 27,810 | +296.7% | 0.01% | +100.0% |
| Q3 2018 | $1,924,000 | +422.8% | 7,010 | +294.5% | 0.00% | +300.0% |
| Q2 2018 | $368,000 | +34.3% | 1,777 | +7.1% | 0.00% | 0.0% |
| Q1 2018 | $274,000 | +33.7% | 1,659 | -1.7% | 0.00% | 0.0% |
| Q2 2017 | $205,000 | -97.4% | 1,688 | -97.8% | 0.00% | -97.1% |
| Q1 2017 | $7,989,000 | +1766.6% | 75,482 | +1787.0% | 0.04% | +1650.0% |
| Q1 2016 | $428,000 | -69.0% | 4,000 | -70.7% | 0.00% | -77.8% |
| Q2 2015 | $1,379,000 | +408.9% | 13,660 | +167.8% | 0.01% | +350.0% |
| Q4 2014 | $271,000 | -47.8% | 5,100 | -38.8% | 0.00% | -71.4% |
| Q2 2014 | $519,000 | – | 8,327 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |